A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
Clinical trial NCT04718103 · COMPLETED
Trial details
- NCT number
- NCT04718103
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-04
- Primary completion
- 2024-04-11
- Enrollment
- 397
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.